Nesibe Selma Çetin

Nesibe Selma Çetin

Auto-generated profile, based on publicly available information

Nesibe Selma Çetin

Affiliations Beykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakıf University, Istanbul, Turkey, Department of Medical Microbiology, Faculty of Medicine, Bezmialem Vakıf University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
EKElif Karaaslan
Elif Karaaslan
NÇNesibe Selma Çetin
Nesibe Selma Çetin
MKMerve Kalkan-Yazıcı
Merve Kalkan-Yazıcı
SHSevde Hasanoğlu
Sevde Hasanoğlu
FKFaruk Karakeçili
Faruk Karakeçili
MDMehmet Ziya Doymaz
Mehmet Ziya Doymaz
In 2019, the World Health Organization declared 3 billion to be at risk of developing Crimean Congo Hemorrhagic Fever (CCHF). The causative agent of this deadly infection is CCHFV. The data related to the biology and immunology of CCHFV are rather scarce. Due to its indispensable roles in the viral life cycle, NP becomes a logical target for detailed viral immunology studies. In this study, humoral immunity to NP was investigated in CCHF survivors, as well as in immunized mice and rabbits. Abundant antibody response against NP was demonstrated both during natural infection in humans and following experimental immunizations in mice and rabbits. Also, cellular immune responses to recombinant NP (rNP) was detected in multispecies. This study represents the most comprehensive investigation on NP as an inducer of both humoral and cellular immunity in multiple hosts and proves that rNP is an excellent candidate warranting further immunological studies specifically on vaccine investigations. Crimean Congo Hemorrhagic Fever Virus (CCHFV) is the most lethal human pathogen of medical importance after the dengue virus among arboviruses. The increasing geographic spread of Hyalomma ticks, which are responsible for viral transmission widespread, threatens billions of people. WHO currently declares the field of research on CCHFV as the second most urgently needed areas of investigations on emerging pathogens. About 10 to 40% of those infected with the virus lose their life due to the rapidly developing severe clinical manifestations. Pandemic potential and the lack of any approved treatment or vaccine make raise the studies on CCHFV as critical. The studies on CCHFV are challenging due to the necessities of BSL-4 facilities and the immunological characterization of individual structural proteins will lay the groundwork for the steps to be taken to treat and prevent this emerging disease. As is known from other RNA viruses, nucleoprotein (NP) has crucial roles in the viral life cycle, both in viral replication and transcription and in the formation of the virion structure. So far, detailed and comprehensive immunological characterizations on NP in multiple are not undertaken. Our study was set out to embark such detailed investigation. The strong humoral and cellular immune response to NP demonstrated by this study indicates that NP might be an excellent candidate for future scrutinies on vaccines and diagnostic reagents.

15 November 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MYMerve Kalkan Yazıcı
Merve Kalkan Yazıcı
MKMeliha Meric Koç
Meliha Meric Koç
NÇNesibe Selma Çetin
Nesibe Selma Çetin
EKElif Karaaslan
Elif Karaaslan
GOGulay Okay
Gulay Okay
MDMehmet Z. Doymaz
Mehmet Z. Doymaz
The recent pandemic of COVID-19 has caused a tremendous alarm around the world. Details of the infection process in the host have significant bearings on both recovery from the disease and on the correlates of the protection from the future exposures. One of these factors is the presence and titers of neutralizing Abs (NAbs) in infected people. In the current study, we set out to investigate NAbs in the recovered subjects discharged from the hospital in full health. Serum samples from a total of 49 documented consecutive COVID-19 subjects were included in the study. All the subjects were adults, and serum samples collected during the discharge were tested in viral neutralization, enzyme immunoassay (EIA), and Western immunoblot tests against viral Ags. Even though a majority of the recovered subjects had raised significant NAb titers, there is a substantial number of recovered patients (10 out of 49) with no or low titers of NAbs against the virus. In these cohorts as well as in patients with high NAb titers, viral Ag binding Abs were detectable in EIA tests. Both NAb titers and EIA detectable Abs are increased in patients experiencing a severe form of the disease, and in older patients the Ab titers were heightened. The main conclusion is that the recovery from SARS-CoV-2 infection is not solely dependent on high NAb titers in affected subjects, and this recovery process is probably produced by a complex interplay between many factors, including immune response, age of the subjects, and viral pathology.

1 April 2024 in Bezmialem Science
Verified
Journal Article
Closed access
NÇNesibe Selma Güler Çeti̇n
Nesibe Selma Güler Çeti̇n
ÖBÖzlem Bakangi̇l
Özlem Bakangi̇l
MYMerve Kalkan Yazici
Merve Kalkan Yazici
SKSercan Keski̇n
Sercan Keski̇n
MDMehmet Ziya Doymaz
Mehmet Ziya Doymaz